About TTI

The Texas Therapeutics Institute at The Brown Foundation Institute of Molecular Medicine (TTI-IMM) was established in 2010 by Dr. C. Thomas Caskey with funding from the Texas Emerging Technology Fund, The University of Texas System, and The University of Texas Health Science Center at Houston. TTI-IMM was created for the discovery, development, and commercialization of therapeutic agents and diagnostic tools. Research conducted at the center focuses on the establishment of proof-of-principle for therapeutics and the identification and validation of drug targets. TTI is located in the Fayez S. Sarofim Research Building, in the heart of the Texas Medical Center. TTI’s mission is to carry out translational research and drug discoveries related to cancer, cardiovascular disease, and stem cells.